SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-058530
Filing Date
2023-12-13
Accepted
2023-12-13 17:30:53
Documents
1
Period of Report
2023-12-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6066
  Complete submission text file 0001209191-23-058530.txt   7608
Mailing Address 550 HAMILTON AVENUE, SUITE 100 PALO ALTO CA 94301
Business Address
Topper James N (Reporting) CIK: 0001341382 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37449 | Film No.: 231485066

Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Issuer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations